中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共7条，第1-7条 帮助

已选(0)清除 条数/页：   排序方式：
Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wei, Jingwen;  Xiang, Jing;  Hao, Yue;  Si, Jinfei;  Wang, Wenxian;  Li, Fangyin;  Song, Zhengbo
收藏  |  浏览/下载：48/0  |  提交时间：2022/12/22
Anemia  Epidermal growth factor receptor  Epidermal growth factor receptor tyrosine kinase inhibitors  Non-small cell lung cancer  
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan;  Zhang, Yiping;  Chen, Ming
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors  
The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients 期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2021
作者:  Cai, Lei;  Chen, Yong;  Tong, Xiaoling;  Wu, Xue;  Bao, Hua;  Shao, Yang;  Luo, Zhuang;  Wang, Xuming;  Cao, Yang
收藏  |  浏览/下载：80/0  |  提交时间：2021/06/15
EGFR  ERBB2  gene fusions  tyrosine kinase inhibitors  young lung cancer patients  
Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer 期刊论文
CANCER MANAGEMENT AND RESEARCH, 2021, 卷号: 13
作者:  Xu, Yi-Bing;  Zhang, Yiping;  Song, Zhengbo;  Wang, Wenxian;  Shao, Lan
收藏  |  浏览/下载：58/0  |  提交时间：2021/09/06
cystic brain metastases  tyrosine kinase inhibitors  chemotherapy  radiation therapy  lung cancer  
Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10
作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun;  Xu, Weizhen;  Shao, Yang;  Yu, Xinmin;  Jin, Ying
收藏  |  浏览/下载：47/0  |  提交时间：2020/10/26
tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)  
Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice 期刊论文
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38
-
收藏  |  浏览/下载：31/0  |  提交时间：2020/10/26
BRAIN METASTASES  CEREBROSPINAL-FLUID  GEFITINIB  INHIBITORS  CARCINOMA  RADIATION  ERLOTINIB  afatinib  tyrosine kinase inhibitor  non-small cell lung cancer  brain metastasis  pharmacokinetic/pharmacodynamics  pEGFR  
Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy 期刊论文
CHINESE MEDICAL JOURNAL, 2014, 卷号: 127
-
收藏  |  浏览/下载：32/0  |  提交时间：2020/10/26
PREVIOUSLY TREATED PATIENTS  TYROSINE KINASE INHIBITORS  FACTOR RECEPTOR MUTATIONS  SKIN RASH  ERLOTINIB EFFICACY  GEFITINIB  EGFR  TRIAL  BENEFIT  ADENOCARCINOMA  non-small cell lung cancer  icotinib  antitumor activity  adverse events